In a teaching session, Competitive antagonist is correctly explained as:

A. An initial larger dose used to achieve a target concentration rapidly. B. A reversible receptor blocker whose effect can be overcome by increasing agonist concentration. C. A drug that irreversibly suppresses the gastric hydrogen-potassium ATPase. D. Presystemic metabolism that reduces oral bioavailability before a drug reaches systemic circulation.